Clinical Trials List
Protocol NumberR092670-PSY-1005
2008-04-01 - 2010-05-31
Phase I
Terminated3
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Completed
Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 賴奕菁 Division of Psychiatry
- 梁欽琦 Division of Psychiatry
- Tzu-Ting Chen Division of Psychiatry
The Actual Total Number of Participants Enrolled
0 Completed
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
224 participants
